Psychosomatic treatment for allergic diseases

Area of Science:

• Psychosomatic Medicine
• Allergology
• Psychiatry

Background:

• Psychosocial stress is linked to allergic disease development and progression, including asthma and atopic dermatitis.
• International asthma guidelines acknowledge psychosocial factors in poor control and exacerbations but lack treatment details.
• Current psychosomatic interventions for asthma patients are not globally standardized due to limited evidence.

Purpose of the Study:

• To review the assessment and treatment of psychosomatic disorders in asthma patients.
• To highlight the framework provided by Japanese guidelines for psychosomatic disease management.
• To identify the need for enhanced evidence to support universal psychosomatic treatment approaches in asthma.

Main Methods:

• Analysis of existing literature on psychosocial stress and allergic diseases.
• Examination of the "Japanese Guidelines for the Diagnosis and Treatment of Psychosomatic Diseases" framework.
• Discussion of the utility of the "Psychosomatic Questionnaire related to Asthmatic Occurrence and Progression" for identifying psychosocial factors.

Main Results:

• Psychosocial factors in asthma are categorized into stress-asthma relations, emotion-symptom links, behavioral issues, Quality of Life (QOL) impact, and life history.
• The Japanese guidelines offer a detailed approach to assessing and treating psychosomatic aspects of asthma.
• A self-administered questionnaire aids in clarifying psychosocial factors and tailoring treatment strategies.

Conclusions:

• Japanese guidelines provide a structured approach to psychosomatic issues in asthma, classifying key psychosocial factors.
• There is a recognized need for more robust empirical evidence to validate and refine these psychosomatic interventions.
• Future research should focus on accumulating high-quality evidence to develop universally applicable psychosomatic treatment strategies for asthma.